Castle Creek Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Castle Creek Biosciences's estimated annual revenue is currently $3.5M per year.
- Castle Creek Biosciences's estimated revenue per employee is $77,500
- Castle Creek Biosciences's total funding is $196.6M.
Employee Data
- Castle Creek Biosciences has 45 Employees.
- Castle Creek Biosciences grew their employee count by -18% last year.
Castle Creek Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Associate VP, Clin Ops | Reveal Email/Phone |
2 | Executive Assistant to President & CEO | Reveal Email/Phone |
3 | Associate VP QA | Reveal Email/Phone |
4 | Sr. VP Regulatory and Quality Affairs | Reveal Email/Phone |
5 | AVP Process Sciences | Reveal Email/Phone |
6 | SVP, Commercial | Reveal Email/Phone |
7 | VP Human Resources | Reveal Email/Phone |
8 | VP Manufacturing | Reveal Email/Phone |
9 | VP Quality | Reveal Email/Phone |
10 | VP, Finance | Reveal Email/Phone |
Castle Creek Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A | N/A |
#2 | $4M | 26 | 13% | N/A | N/A |
#3 | $0.9M | 6 | -14% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $10.9M | 70 | 3% | N/A | N/A |
#6 | $0.7M | 9 | 29% | N/A | N/A |
#7 | $4M | 26 | -16% | N/A | N/A |
#8 | $1.7M | 11 | 22% | N/A | N/A |
#9 | $7.6M | 49 | 2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Castle Creek Biosciences?
Castle Creek Biosciences, Inc. is a privately-held, clinical-stage cell and gene therapy company advancing innovative personalized therapies for underserved disorders with high unmet medical needs.
keywords:N/A
$196.6M
Total Funding
45
Number of Employees
$3.5M
Revenue (est)
-18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Castle Creek Biosciences News
Novartis AG. Gilead Sciences, Inc. Castle Creek Biosciences, Inc; Lineage Cell Therapeutics, Inc. Transgene SA; Cellectis; ImmunityBio, Inc...
... Treatment Market Report Covers Future Trends With Research 2022 to 2029 Krystal Biotech, Castle Creek Biosciences, Abeona Therapeutics.
... founded by Paragon Biosciences, announced today that it has ... The company's current portfolio includes Castle Creek Biosciences,...
EXTON, Pa., Sept. 29, 2021 /PRNewswire/ -- Castle Creek Biosciences, Inc., a clinical-stage cell and gene therapy company focused on developing and commercializing disease-modifying therapies for patients suffering from rare diseases for which there is a lack of available treatment options, toda ...
Castle Creek Biosciences, Inc., an Exton, Pa.-based late-stage gene therapy company, received $75m in equity and debt funding. Paragon Biosciences led the $55m equity investment with participation from Fidelity Management & Research Company and Valor Equity Partners. A $20m venture loan was pro ...
Other Companies in Exton
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $13M | 46 | 7% | N/A |
#2 | $9.2M | 47 | 4% | N/A |
#3 | $5.6M | 48 | 55% | N/A |
#4 | $3.9M | 49 | 4% | N/A |
#5 | $3.5M | 49 | 4% | N/A |